-
Apollo Hospitals
6,900.70 5,690.80(%) -
Waaree Energies
2,590.20 1,808.65(%) -
Reliance Industr
1,288.00 1,115.55(%) -
SpiceJet
55.49 79.90(%) -
Axis Bank
1,145.75 934.00(%) -
Dixon Technolog.
16,092.55 7,935.00(%) -
Suzlon Energy
56.78 37.95(%) -
Vodafone Idea
7.44 6.60(%) -
SBI Life Insuran
1,763.00 1,935.00(%) -
Tata Motors
651.45 542.55(%) -
Bharat Electron
293.70 221.00(%) -
Tata Power Co.
382.00 326.25(%) -
Reliance Power
40.91 23.26(%) -
Eternal Ltd
226.95 146.85(%) -
HDFC Bank
1,891.90 1,430.15(%) -
Jio Financial
249.15 198.60(%) -
Mazagon Dock
2,585.00 1,046.00(%) -
Adani Energy Sol
907.00 588.25(%) -
Nip. India Nifty
266.61 242.12(%) -
Adani Green
904.00 758.00(%)
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
Glaxosmithkline Pharmaceuticals Ltd Pharmaceuticals - Multinational
- MNC Asc-Glaxo
- BSE Code : 195.0
- ISIN : INE159A01016
-
Today’s Low
2,780.00 -
Today’s High
2,944.80

-
Open
2,941.50 -
Perv Close
2,916.00 -
52W Low
1,921.00 -
52W High
3,148.00
Key Indicators
-
P/E(TTM)
56.09
-
Mar.Cap (₹Cr.)
47,479.43
-
Div & Yield %
1.14
-
Book Value(₹)
98.85
-
Debt-Equity Ratio
-3.89
-
AGM Date
25-Apr-2025
-
EPS
49.99
-
P/E Ratio
56.09
Financials Ratios
-
Debt-Equity Ratio
0.01
-
Mar.Cap (₹Cr.)
47,479.43
-
RONW (%)
37.32
-
ROCE (%)
44.97
Score Board
-
Equity (₹ in Cr.)
169.41
-
BV (₹)
98.90
-
Sales( ₹ in Cr.)
3,407.25
-
NP (in Cr.)
651.27
-
NP Var(%)
11.0
-
Div%
320.0
-
CPS (₹)
42.60
-
EPS (₹)
38.40
-
Traded Value (₹ in Lakhs)
47,502.30
-
52 Week High
3,148.00
-
52 Week Low
1,921.00
-
Price BSE
2804.0
-
Price NSE
2,803.00
-
Market Capital( in Cr.)
47,502.30
-
P/C Ratio
65.90
-
P/E Ratio
72.90
-
Price Vs.BV
38.40
-
19-Apr-2025( 09:56)
Corporate News - Glaxo... - GlaxoSmithKline Pharmaceutical...
-
14-Feb-2025( 05:57)
Results - Announcements - Glaxo... - Net profit of Glaxosmithkline...
-
06-Feb-2025( 12:00)
Hot Pursuit - Glaxo... - <p>Spandana Sphoorty Financial...
-
21-Jan-2025( 11:16)
Corporate News - Glaxo... - GlaxoSmithKline Pharmaceutical...
Navigate The Market With Confidence
Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions
Financials
All Values are in (₹Cr)Particulars(INCOME) | 2024 Mar | 2023 Mar | 2022 Mar | 2021 Mar | 2020 Mar | 2019 Mar |
---|---|---|---|---|---|---|
INCOME : | ||||||
Sales Turnover | 3,407.25 | 3,216.34 | 3,217.51 | 2,920.48 | 3,224.68 | 3,128.53 |
Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Sales | 3,407.25 | 3,216.34 | 3,217.51 | 2,920.48 | 3,224.68 | 3,128.53 |
Other Income | 143.17 | 114.96 | 1,423.27 | 217.71 | 624.37 | 149.56 |
Stock Adjustments | 69.64 | -67.25 | -13.83 | 26.12 | 35.43 | -25.57 |
Total Income | 3,620.06 | 3,264.05 | 4,626.95 | 3,164.31 | 3,884.48 | 3,252.52 |
EXPENDITURE : | ||||||
Raw Materials | 1,358.07 | 1,182.78 | 1,281.91 | 1,275.49 | 1,343.30 | 1,327.96 |
Power and Fuel Cost | 29.64 | 29.60 | 27.83 | 26.08 | 33.36 | 27.94 |
Employee Cost | 624.39 | 594.99 | 610.23 | 616.16 | 628.55 | 537.20 |
Other Manufacturing Expenses | 113.61 | 99.05 | 120.14 | 110.59 | 107.88 | 115.19 |
Selling and Administration Expenses | 374.71 | 370.30 | 343.57 | 242.00 | 376.68 | 381.32 |
Miscellaneous Expenses | 239.12 | 84.32 | 85.69 | 287.75 | 983.19 | 150.08 |
Employee Benefit Expenses | 624.39 | 594.99 | 610.23 | 616.16 | 628.55 | 537.20 |
Less: Preoperative Expenditure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Expenses | 2,739.54 | 2,361.04 | 2,469.38 | 2,558.07 | 3,472.96 | 2,539.68 |
Operating Profit | 880.52 | 903.01 | 2,157.57 | 606.24 | 411.52 | 712.85 |
Interest | 1.80 | 1.81 | 1.99 | 3.53 | 6.34 | 0.55 |
Gross Profit | 878.72 | 901.20 | 2,155.58 | 602.71 | 405.18 | 712.30 |
Depreciation | 69.68 | 65.77 | 68.19 | 78.60 | 82.68 | 48.59 |
Profit Before Tax | 809.04 | 835.43 | 2,087.39 | 524.11 | 322.50 | 663.71 |
Current Tax | 235.71 | 246.05 | 407.36 | 158.67 | 260.17 | 192.82 |
Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Deferred Tax | -11.36 | -18.37 | -10.49 | 7.87 | -47.72 | 45.52 |
Reported Net Profit | 584.69 | 607.75 | 1,690.53 | 357.57 | 110.05 | 425.36 |
Extraordinary Items | -66.58 | 21.05 | 11.18 | -117.79 | -87.09 | 4.04 |
Adjusted Net Profit | 651.27 | 586.70 | 1,679.35 | 475.36 | 197.14 | 421.32 |
Adjustment below Net Profit | -21.25 | -17.08 | -11.05 | 0.00 | -73.62 | -64.12 |
P & L Balance brought forward | 828.12 | 1,745.02 | 562.71 | 882.77 | 1,177.99 | 1,113.21 |
Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Appropriations | 542.10 | 1,524.66 | 508.22 | 677.62 | 338.81 | 296.46 |
P & L Balance carried down | 849.46 | 811.03 | 1,733.98 | 562.71 | 875.62 | 1,177.99 |
Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Equity Dividend (%) | 320.00 | 320.00 | 900.00 | 300.00 | 400.00 | 200.00 |
Dividend Per Share(Rs) | 32.00 | 32.00 | 90.00 | 30.00 | 40.00 | 20.00 |
Earnings Per Share-Unit Curr | 34.51 | 35.88 | 99.79 | 21.11 | 6.50 | 25.11 |
Earnings Per Share(Adj)-Unit Curr | 34.51 | 35.88 | 99.79 | 21.11 | 6.50 | 25.11 |
Book Value | 105.31 | 103.48 | 158.06 | 88.37 | 108.62 | 126.47 |
Book Value(Adj)-Unit Curr | 105.31 | 103.48 | 158.06 | 88.37 | 108.62 | 126.47 |